Sorensen Mel

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 56% 8.2% 15.1%
Success rate 99% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -97%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Sorensen Mel's trades of Galera Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
289.73
Quantity 816
Value US$4,580,759
Transaction date
Sale
Price
152.66
Quantity 27,247 -46.7%
Value US$3,196,554
Transaction date
Proposed sale
Price
0.07
Quantity 67,015
Value US$4,825
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-24 2025-11-20
S Sale
3,343 +1.0%
235.78
US$464,447 		3,343 +1.0% 235.78 US$464,447
2025-11-20 2025-11-20
PrS Proposed sale
816
289.73
US$4,580,759 		816 289.73 US$4,580,759
2024-08-20 2024-08-16
S Sale
27,247 -46.7%
152.66
US$3,196,554 		27,247 -46.7% 152.66 US$3,196,554
2024-08-16 2024-08-16
PrS Proposed sale
67,015
0.07
US$4,825 		67,015 0.07 US$4,825
2023-03-14 2023-03-10
B Purchase
100,000 +43.1%
1.68
US$168,120 		100,000 +43.1% 1.68 US$168,120